Zobrazeno 1 - 5 of 5 pro vyhledávání: '"P. M. L. H. Vencken"'
1
P4-11-04: Risk of Primary (PBC) and Contralateral Breast Cancer (CBC) after Ovarian Cancer (OC) in BRCA1 and BRCA2 Mutation Carriers; Implications for Surveillance and Risk Reducing Mastectomy
Autor: M.J. Hooning, Curt W. Burger, Caroline Seynaeve, A. Heemskerk-Gerritsen, Montfort K Van, A. Jager, Margriet Collée, Marian B. E. Menke-Pluymers, Doorn L Van, P. M. L. H. Vencken, Mieke Kriege
Publikováno v: Cancer Research. 71:P4-11
Background In view of the increased risk of developing breast (BC) cancer, BRCA mutation carriers are offered intensive surveillance or risk reducing mastectomy (RRM) and/or salpingo-ovariectomy (RRSO). It is insufficiently clear how to counsel mutat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97326e8743df09922cd7e5e080b32536
https://doi.org/10.1158/0008-5472.sabcs11-p4-11-04
Zobrazit plný text záznamu
2
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
Autor: Marjanka K. Schmidt, Mieke Kriege, J.A. de Hullu, Katja N. Gaarenstroom, P. M. L. H. Vencken, Brigitte F. M. Slangen, M. van Beurden, Ronald P. Zweemer, AM van Altena, Marian J.E. Mourits, Muriel A. Adank, Curt W. Burger, G. H. de Bock, Fleur E.M. Rijcken, Caroline Seynaeve, Welmoed Reitsma, Hans F. A. Vasen
Publikováno v: Annals of Oncology, 24(8), 2036-2042. Oxford University Press
Annals of Oncology, 24(8), 2036-2042. Elsevier Ltd.
Annals of Oncology, 24, 2036-42
Annals of oncology, 24(8), 2036-2042. Oxford University Press
Annals of Oncology, 24, 8, pp. 2036-42
Annals of Oncology, 24(8), 2036-2042
Vencken, P M L H, Reitsma, W, Kriege, M, Mourits, M J E, de Bock, G H, de Hullu, J A, van Altena, A M, Gaarenstroom, K N, Vasen, H F A, Adank, M A, Schmidt, M K, van Beurden, M, Zweemer, R P, Rijcken, F, Slangen, B F M, Burger, C W & Seynaeve, C 2013, ' Outcome of BRCA1-compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands ', Annals of Oncology, vol. 24, no. 8, pp. 2036-2042 . https://doi.org/10.1093/annonc/mdt068
Item does not contain fulltext BACKGROUND: Recent studies suggested an improved overall survival (OS) for BRCA2- versus BRCA1-associated epithelial ovarian cancer (EOC), whereas the impact of chemotherapy is not yet clear. In a nationwide cohort, we
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241a28f70c600a3764b032fe82c26c85
https://doi.org/10.1093/annonc/mdt068
Zobrazit plný text záznamu
3
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
Autor: Mieke Kriege, Els M.J.J. Berns, S. Beugelink, P. M. L. H. Vencken, D. Hoogwerf, Maartje J. Hooning, Agnes Jager, Caroline Seynaeve, Curt W. Burger, M.E.L. van der Burg, Margriet Collée
Publikováno v: Annals of Oncology, 22(6), 1346-1352. Elsevier Ltd.
Background Because it is insufficiently clear whether BRCA-associated epithelial ovarian cancer (EOC) is more chemosensitive than sporadic EOC, we examined response to chemotherapy, progression-free survival (PFS) and overall survival (OS) in BRCA1-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340a25c13a09b54f4b58d9da471d2d4e
https://pubmed.ncbi.nlm.nih.gov/21228333
Zobrazit plný text záznamu
5
Akademický článek
Epithelioid trophoblastic tumour: a case report and review of the literature.
Autor: P M L H Vencken
Publikováno v: Journal of Clinical Pathology; Dec2006, Vol. 59 Issue 12, p1307-1308, 2p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje